Search clinical trials for: Vakcína

Total 7025 results

Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Pandemic Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
European Malaria Vaccine Initiative
University of Oxford; Wellcome Trust

Completed

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Malaria | Malaria, Falciparum

United Kingdom
Kirby Institute
The University of New South Wales; Virax Pty. Ltd,

Completed

ITV Extension Study

HIV

Australia
Ruhr University of Bochum

Completed

Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes (AGE-Benfo)

Type 2 Diabetes Mellitus | Endothelial Dysfunction

Germany
University Health Network, Toronto

Unknown

Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine

Transplant

Canada
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous

Peru
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

Brazil
Henogen

Completed

Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).

Epstein Barr Virus (EBV) Infection

Belgium
PowderMed

Completed

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

HSV-2

United States
PowderMed

Completed

Safety Study of an Influenza Vaccine Against a Potential Pandemic Strain of Flu

Influenza (Pandemic)

United Kingdom
PowderMed

Completed

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

Influenza

United Kingdom
PowderMed

Completed

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

Influenza

United States
ID Biomedical Corporation, Quebec

Completed

Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over

Influenza

United States
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

Tuberculosis

Gambia
VaxGen

Unknown

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

Smallpox

United States
University of California, San Francisco
Vical

Completed

Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM

Cytomegalovirus Infection
Probiomics Ltd

Unknown

Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines

Influenza

Australia
Epicentre
University of Oslo; Norwegian Institute of Public Health; Medecins Sans Frontieres...

Completed

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Infections, Meningococcal | Meningitis, Meningococcic

Norway, Uganda
National Taiwan University Hospital

Unknown

Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions

Cervical Cancer

Taiwan
ID Biomedical Corporation, Quebec

Unknown

Study of the Protective Effect of an Injectable Influenza Vaccine Against Influenza Illness in Adults Under 50 y.o.

Influenza

United States
GlaxoSmithKline

Completed

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Hib Diseases | Neisseria Meningitidis Serogroups A & C Diseases

Philippines
University of Oxford
Medical Research Council; Walter Reed Army Institute of Research (WRAIR); Swiss... and other collaborators

Completed

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

Malaria | Malaria, Falciparum

United Kingdom
The Cleveland Clinic

Completed

Improving Influenza Vaccination Rates Among Health Care Professionals

Influenza

United States
University Hospital, Antwerp
Universiteit Antwerpen; Eurogenerics NV

Completed

Effectiveness of Influenza Vaccination Among General Practitioners

Influenza
Swiss Tropical & Public Health Institute

Terminated

Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Peptides

Falciparum Malaria
International Vaccine Institute
Göteborg University; National Institute of Hygiene and Epidemiology, Vietnam

Completed

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Cholera

Vietnam
Novartis
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

Meningococcal Infection

Germany
Odense University Hospital

Completed

Rituximab in the Treatment of Graves' Disease

Thyroid Associated Ophthalmopathy | Graves´ Disease

Denmark
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Influenza

Finland
Novartis
Novartis Vaccines; Chiron s.r.l. Beijing Representative Office

Completed

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

Influenza

China
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.

Influenza

Italy
Danish Headache Center

Unknown

Effect of GTN and Diamox Measured by BOLD-Response.

Healthy

Denmark
Julius-Maximilians University

Unknown

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Cervical Cancer | Pancreatic Cancer | Colon Cancer | Malignant Melanoma

Germany
Cancer Research UK
Oxford BioMedica

Completed

Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed

Colorectal Neoplasms
Nabi Biopharmaceuticals

Completed

Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis

Kidney Failure, Chronic | Staphylococcal Infections
Mackay Memorial Hospital

Unknown

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Carcinoma, Hepatocellular
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
IDRI
Bill and Melinda Gates Foundation

Completed

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
National Center for Research Resources (NCRR)
Northwestern University

Unknown

Study of Novel Types of Familial Diabetes Insipidus

Diabetes Insipidus
VaxGen
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Completed

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

Anthrax

United States
IDEWE Occupational Health Services
GlaxoSmithKline

Unknown

Twinrix Alternative Schedule Study

Antibody Response After Vaccination

Belgium
Chiron Corporation

Unknown

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Meningococcal Disease; Meningococcal Meningitis

United Kingdom
Pan American Health Organization
Centers for Disease Control and Prevention; World Health Organization; Institute...

Completed

Study of Inactivated Poliovirus Vaccine Given at an Earlier Schedule With Shorter Intervals

Level of Immunity Against Poliovirus Infection
Johns Hopkins Bloomberg School of Public Health
London School of Hygiene and Tropical Medicine; Burroughs Wellcome; University...

Completed

Impact of HIV on Measles and Measles Immunisation

HIV Infection | Measles | Children

Zambia
Cell Genesys

Completed

A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Nonresectable Pancreatic Cancer

United States

3

Subscribe